Dive into the latest survey results for the Biotech Showcase™ 2019 Investment Trends Survey. See the responses for questions covering topics such as how biotech investment may change due to US stock market volatility, the US and China trade war, in the UK exit from the EU. Overall, results reflect a bright outlook for US biotech investment but signal potential challenges abroad.
Key highlights from the 2019 Biotech Showcase survey include:
- A majority (65 percent) of life science investors and executives expect to see an increase in investment during 2019
- Biotech leaders think cell and gene therapy is poised to have biggest breakthrough in 2019 among the major categories
- China is predicted to see the biggest percentage increase in 2019 biotech investment dollars when compared to other global biotech hot spots
- Life science leaders do not expect the US and China trade war to have an impact on their regional strategies, but they do expect it will have long-term impact on investments coming from that region
- 75 percent of investors expect to see a decrease in investments in the UK when it exits from the EU in March; other markets will see an increase or remain unchanged
*Survey was sent to the 2018 list of registered Biotech Showcase attendees. 80 people provided responses.
